Phase II Trial of Ofatumumab and Fresh Frozen Plasma in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 10 Jul 2017
At a glance
- Drugs Ofatumumab (Primary)
- Indications Chronic lymphocytic leukaemia
- Focus Therapeutic Use
- 05 Jul 2017 Status changed from recruiting to active, no longer recruiting.
- 10 Jan 2017 Planned End Date changed from 1 Jan 2017 to 1 Jan 2018.
- 20 Dec 2016 Planned End Date changed from 1 Jan 2016 to 1 Jan 2017.